Latest Breaking News On - Irene wapnir - Page 1 : comparemela.com

Lumicell s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer

Lumicell s Cutting-Edge Imaging Platform Receives Historic FDA Approval to Illuminate Residual Breast Cancer
itnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itnonline.com Daily Mail and Mail on Sunday newspapers.

United statesBarbara smithJorge ferrerIrene wapnirHoward hechlerSociety of surgical oncologyStanford university school of medicineUs food drug administrationDepartment of breast surgical oncologyLumicell incMd anderson cancer centerProfessor of surgery at harvard medical schoolBreast program at massachusettsDrug administrationNew drug applicationPremarket approval

FDA Greenlights Imaging Agent to Detect Residual Cancer After Lumpectomy

Pegulicianine used with an approved imaging system achieved overall diagnostic accuracy of 84%

United statesStanford universityBarbara smithCharles bankheadIrene wapnirStanford university medical centerLumicell direct visualization systemMass general brighamMedpage today

New Study Shows the Effectiveness of Mammograms in Detecting Second Breast Cancers in DCIS Patients

Discover the latest study of breast cancer surveillance in women with DCIS history, highlighting the importance of mammograms and self-exams.

United statesIrene wapnirTaria kingNational comprehensive cancer networkKaiser permanente medical centersDana farber brigham cancer centerNorthern californiaBreast cancer stagesWhat do theyBreast cancer careWomen withComprehensive cancer networkBreast cancer screeningNavigate through yourStanford medicinePalo alto

Lumicell Introduces Further Research and Insights in Fluorescence-Guided Surgery at the Society of Surgical Oncology (SSO) Annual Meeting

NEWTON, Mass., March 25, 2024 Lumicell Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer detection during surgery, highlights presentations from clinical studies examining the use of investigational LUMISIGHT™ (pegulicianine) in combination with Lumicell™ Direct Visualization System (DVS) at the Society of Surgical Oncology Annual Meeting in Atlanta, Georgia, March 20-23, 2024.

United statesJorge ferrerBarbara smithIrene wapnirImaging drugs advisory committeeMd anderson cancer centerBreast program at massachusettsDepartment of breast surgeryDepartment of surgeryStanford university medical centerUniversity of iowa hospitalsLumicell incKey studies examinedDirect visualization systemSurgical oncology annual meetingBreast surgery